Status:
COMPLETED
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
Lead Sponsor:
University of Aarhus
Conditions:
Hypopituitarism
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
In growth hormone deficient patients: Determination of endogenous circulating ghrelin levels, ghrelin effects on insulin sensitivity, appetite, energy metabolism, and signal transduction in fat and mu...
Eligibility Criteria
Inclusion
- Age between 18 and 60 yrs.
- Verified hypopituitarism
- Unchanged substitution treatment through 3+ months
- Unchanged additional medical treatment
- Oral and written informed consent
Exclusion
- Age below 18 or above 60 yrs.
- Diabetes mellitus
- body mass index \> 30
- Fasting hypoglycemia
- Convulsions
- Allergy to trial products
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00139945
Start Date
October 1 2005
End Date
March 1 2007
Last Update
January 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8000